IM Cannabis (IMCC) Consolidated Net Income (2020 - 2026)
IM Cannabis (IMCC) recorded quarterly Consolidated Net Income of -$1.9 million in Q1 2026, up 67.05% quarter-over-quarter from -$5.6 million in Q4 2025, and down 2379.57% on a YoY basis from $81539.2 in Q1 2025.
IM Cannabis (IMCC) Consolidated Net Income (2020 - 2026) Analysis & Trends
IM Cannabis' Consolidated Net Income history runs 7 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- In Q1 2026, Consolidated Net Income fell 2379.57% year-over-year to -$1.9 million; the TTM figure through Mar 2026 stood at -$10.4 million (down 154.4% YoY), while the FY2025 annual figure was -$8.4 million, changed N/A from the prior year.
- Consolidated Net Income was -$1.9 million for Q1 2026 at IM Cannabis, up from -$5.6 million in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $2.9 million in Q1 2022 to a low of -$94.8 million in Q3 2022.
- Historically, Consolidated Net Income has averaged -$9.5 million across 5 years, with a median of -$2.2 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Consolidated Net Income soared 101.76% in 2025, then slumped 2379.57% in 2026.
- A 5-year view of Consolidated Net Income shows it stood at -$17.5 million in 2022, then advanced by 29.04% to -$12.4 million in 2023, then soared by 93.02% to -$868325.0 in 2024, then tumbled by 549.6% to -$5.6 million in 2025, then surged by 67.05% to -$1.9 million in 2026.
- The last three Consolidated Net Income figures came in at -$1.9 million (Q1 2026), -$5.6 million (Q4 2025), and -$2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | IM Cannabis | 57,090.22 | -728,264.31 | 1.03 Mn | -1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.86 Mn |
| Dec 31, 2025 | -5.64 Mn |
| Sep 30, 2025 | -2.81 Mn |
| Jun 30, 2025 | -140,012.22 |
| Mar 31, 2025 | 81,539.23 |
| Dec 31, 2024 | -868,325.01 |
| Sep 30, 2024 | -793,163.79 |
| Jun 30, 2024 | -2.53 Mn |
| Mar 31, 2024 | -4.63 Mn |
| Dec 31, 2023 | -12.44 Mn |
| Sep 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | -640,577.05 |
| Dec 31, 2022 | -17.53 Mn |
| Sep 30, 2022 | -94.80 Mn |
| Jun 30, 2022 | -11.98 Mn |
| Mar 31, 2022 | 2.89 Mn |
| Dec 31, 2021 | -3.27 Mn |
| Sep 30, 2021 | -5.15 Mn |
| Jun 30, 2021 | -4.14 Mn |
| Mar 31, 2021 | 3.73 Mn |